Literature DB >> 15782425

Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers.

Jayne E Bailey1, Spilios V Argyropoulos, Adrian H Kendrick, David J Nutt.   

Abstract

The study of carbon dioxide (CO2) inhalation in psychiatry has a long and varied history, with recent interest in using inhaled CO2 as an experimental tool to explore the neurobiology and treatment of panic disorder. As a consequence, many studies have examined the panic-like response to the gas either using the single or double breath 35% CO2 inhalation or 5-7% CO2 inhaled for 15-20 min, or rebreathing 5% CO2 for a shorter time. However, this lower dose regime produces little physiological or psychological effects in normal volunteers. For this reason we have studied the effects of a higher concentration of CO2, 7.5%, given over 20 min. Twenty healthy volunteers were recruited to a double blind, placebo-controlled study where air and 7.5% CO2 were inhaled for 20 min. Cardiovascular measures and subjective ratings were obtained. When compared to air, inhaling 7.5% CO2 for 20 min increases systolic blood pressure and heart rate, indicating increased autonomic arousal. It also increases ratings of anxiety and fear and other subjective symptoms associated with an anxiety state. The inhalation of 7.5% CO2 for 20 min is safe for use in healthy volunteers and produces robust subjective and objective effects. It seems promising as an anxiety provocation test that could be beneficial in the study of the effects of anxiety on sustained performance, the discovery of novel anxiolytic agents, and the study of brain circuits and mechanisms of anxiety. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15782425     DOI: 10.1002/da.20048

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  40 in total

Review 1.  Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences.

Authors:  Christian Grillon; Oliver J Robinson; Brian Cornwell; Monique Ernst
Journal:  Neuropsychopharmacology       Date:  2019-06-21       Impact factor: 7.853

2.  Inhalation of 7.5% carbon dioxide increases threat processing in humans.

Authors:  Matthew Garner; Angela Attwood; David S Baldwin; Alexandra James; Marcus R Munafò
Journal:  Neuropsychopharmacology       Date:  2011-04-13       Impact factor: 7.853

Review 3.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 4.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

5.  Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia.

Authors:  Philip L Johnson; Brian C Samuels; Stephanie D Fitz; Stafford L Lightman; Christopher A Lowry; Anantha Shekhar
Journal:  Neuropsychopharmacology       Date:  2012-03-28       Impact factor: 7.853

6.  Inhalation of 7.5% carbon dioxide increases alerting and orienting attention network function.

Authors:  Matthew Garner; Angela Attwood; David S Baldwin; Marcus R Munafò
Journal:  Psychopharmacology (Berl)       Date:  2012-03-29       Impact factor: 4.530

Review 7.  Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks.

Authors:  Philip L Johnson; Lauren M Federici; Anantha Shekhar
Journal:  Neurosci Biobehav Rev       Date:  2014-08-15       Impact factor: 8.989

8.  Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.

Authors:  Sean D Hood; Dana A Hince; Simon J C Davies; Spilios Argyropoulos; Hayley Robinson; John Potokar; David J Nutt
Journal:  Psychopharmacology (Berl)       Date:  2009-11-21       Impact factor: 4.530

9.  The Twin Study of Negative Valence Emotional Constructs.

Authors:  Dever M Carney; Elizabeth Moroney; Laura Machlin; Shannon Hahn; Jeanne E Savage; Minyoung Lee; Kenneth A Towbin; Melissa A Brotman; Daniel S Pine; Ellen Leibenluft; Roxann Roberson-Nay; John M Hettema
Journal:  Twin Res Hum Genet       Date:  2016-07-26       Impact factor: 1.587

10.  Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.

Authors:  J M P Baas; N Mol; J L Kenemans; E P Prinssen; I Niklson; C Xia-Chen; F Broeyer; J van Gerven
Journal:  Psychopharmacology (Berl)       Date:  2009-05-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.